Fred Hutchinson scientists have identified biomarkers associated with dangerous side effects possible in cancer patients treated with CAR-T cells.

Scientists from the Wellcome Trust Sanger Institute have created a new type of stem cell that retains the ability to develop into any type of cell.

Stanford scientists have identified a pathway that allows the p53 protein to exert antitumor effects on pancreatic tumors.

The past week brought news of discoveries in prostate cancer, Alzheimer's and dementia, and acute myeloid leukemia.

A synthetic DNA vaccine developed by the Wistar Institute and Penn scientists, with support from Inovio and GeneOne, shows promise in human trials.

UC Berkeley scientists are using a new CRISPR delivery system to more safely correct the mutated dystrophin gene in mouse models of DMD.

Scientists at Baylor have discovered that when they silence a signaling pathway in the body called Hippo, they can reverse heart failure in mice.

This past week ushered in new developments in the fight against retinitis pigmentosa, heart failure and pancreatic cancer.

Two commonly mutated genes in lung cancer may make some tumor cells especially vulnerable to an experimental drug from Calithera Biosciences.

Scientists at Yale believe they’ve found an immune connection to the inability to burn belly fat—and a possible solution.